Last update 23 Jan 2025

Chugai Pharmaceutical Company Limited Beijing Representative Office

Private Company|
1995|
Beijing Shi, China

Overview

Related

1
Drugs associated with Chugai Pharmaceutical Company Limited Beijing Representative Office
Eldecalcitol
Target
VDR
Mechanism
VDR agonists
Active Org.
Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
Originator Org.
Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.
Active Indication
Osteoporosis
Inactive Indication
Osteoporotic Fractures [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date21 Jan 2011
2
Clinical Trials associated with Chugai Pharmaceutical Company Limited Beijing Representative Office
CTR20160430
/ CompletedPhase 1
ED-71单次给药在健康成年男性志愿者中的安全性和药代动力学研究-一项开放、随机、双剂量、双周期交叉临床试验
[Translation] Safety and pharmacokinetics of a single dose of ED-71 in healthy adult male volunteers: an open, randomized, double-dose, double-period crossover clinical trial
CTR20150300
/ CompletedPhase 3
以腰椎骨密度为指标、针对原发性骨质疏松症的与阿法骨化醇的对照试验
[Translation] A controlled trial with alfacalcidol for primary osteoporosis using lumbar spine bone mineral density as an indicator
100 Clinical Results associated with Chugai Pharmaceutical Company Limited Beijing Representative Office
Login to view more data
0 Patents (Medical) associated with Chugai Pharmaceutical Company Limited Beijing Representative Office
Login to view more data
100 Deals associated with Chugai Pharmaceutical Company Limited Beijing Representative Office
Login to view more data
100 Translational Medicine associated with Chugai Pharmaceutical Company Limited Beijing Representative Office
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 02 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Eldecalcitol
 ( VDR )		Primary osteoporosis
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free